Sangeeta Jiwatani

Statistics

Publications

Citations

H-Index

Active since

2004

Affiliations

Nizam's Institute of Medical Sciences(Current)

Dr. Reddy's Laboratories (United States)

Dr. Reddy's Laboratories (India)

Sangeeta Jiwatani is an author at Nizam's Institute of Medical Sciences specializing in refractory solid tumors, pharmacokinetics of anticancer drugs, and oncology pharmacology.

Publications per year

2004–2014

Publications

Incidence of Bcr-Abl kinase domain mutations in imatinib refractory chronic myeloid leukemia patients from South India

Sailaja Kagita, Srihari Uppalapati, Sangeeta Jiwatani et al. · Tumor Biology · 2014 · 18 citations

Life Sciences, Genetics, Hematology +11

Safety, Tolerability, and Pharmacokinetics of a Capsule Formulation of DRF‐1042, a Novel Camptothecin Analog, in Refractory Cancer Patients in a Bridging Phase I Study

Arani Chatterjee, Raghunadharao Digumarti, Kasiram Katneni et al. · The Journal of Clinical Pharmacology · 2005 · 18 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of an Orally Active Novel Camptothecin Analog, DRF‐1042, in Refractory Cancer Patients in a Phase I Dose Escalation Study

Arani Chatterjee, Raghunadharao Digumarti, Rao N. V. S. Mamidi et al. · The Journal of Clinical Pharmacology · 2004 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +17

1–3 of 3